A graded system to categorize drug-resistant epilepsy

Epilepsia

Volumn 51, Issue 11, 2010, Pages 2360-2361

  Gomez Alonso, Juan ^a   Gil Nagel, Antonio ^b  

^a HOSPITAL XERAL CÍES   (Spain)

^b HOSPITAL RUBER INTERNACIONAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT;

CLINICAL CLASSIFICATION; CLINICAL TRIAL; COHORT ANALYSIS; DISEASE CLASSIFICATION; DRUG EFFICACY; DRUG TREATMENT FAILURE; EPILEPSY; GENERAL PRACTITIONER; HUMAN; LETTER; NEUROSURGERY; OUTCOME ASSESSMENT; PATIENT REFERRAL; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEIZURE; UNSPECIFIED SIDE EFFECT;

ANTICONVULSANTS; CONSENSUS; DRUG RESISTANCE; EPILEPSY; HUMANS;

EID: 78349293062     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2010.02737.x     Document Type: Letter

References (4)

1. Kwan P, Brodie MJ,. (2000) Early identification of refractory epilepsy. N Engl J Med 342: 314 - 319.
2. Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Hauser WA, Mathern G, Moshé SL, Perucca E, Wiebe S, French J,. (2010) Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 51: 1069 - 1077.
3. Perucca E,. (1998) Pharmacoresistance in epilepsy. How should it be defined? CNS Drugs 10: 171 - 179.
4. Schiller Y, Najjar Y,. (2008) Quantifying the response to antiepileptic drugs. Effect of past treatment history. Neurology 70: 54 - 65.